2024
Rethinking Our Roots: The Ground-Up Approach to Heart Health & Planetary Sustainability
Saad A, Brandt E, Faridi K, Paster J, Sheth S, Freeman A, Ramirez V, Aggarwal M. Rethinking Our Roots: The Ground-Up Approach to Heart Health & Planetary Sustainability. The American Journal Of Medicine 2024 PMID: 39383927, DOI: 10.1016/j.amjmed.2024.09.028.Peer-Reviewed Original ResearchPlanetary healthCardiovascular diseasePromote planetary healthPoor dietary habitsModifiable risk factorsNutrition educationChronic illnessDietary habitsFood insecurityRisk factorsHealthPlant-forward dietsTreat cardiovascular diseasesUnited StatesFood systemsAgricultural practicesDiseasePracticeComplex issuesIllnessNutritionHabitsEducationProposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Reddy K, Faridi K, Aggarwal M, Tirumalai A, Singh T, Tejtel K, Williams K, Litwin S, Dastmalchi L, White B, Barnard N, Ornish D, Batts T, Ajene G, Aspry K, Kris Etherton P, Hull S, Freeman A. Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors. American Journal Of Lifestyle Medicine 2024 DOI: 10.1177/15598276241269532.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCardiometabolic riskLifestyle choicesCardiovascular diseaseHealthy lifestyle choicesCardiometabolic risk factorsHealth promotionReduce disease burdenCode BlueCardiovascular healthDisease preventionCOVID-19 morbidityPoor nutritionDisease burdenCOVID-19Disease burden resultsPublic healthGlobal leading causeLeading causeRisk factorsAssociation of COVID-19HealthLifestyleBurden resultsNutritionCardiovascular medicineSerum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors
Faridi K, Lahan S, Budoff M, Cury R, Feldman T, Pan A, Fialkow J, Nasir K. Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors. JACC Advances 2024, 3: 101049. PMID: 39129991, PMCID: PMC11312344, DOI: 10.1016/j.jacadv.2024.101049.Peer-Reviewed Original ResearchTraditional risk factorsNon-HDL-CLDL-CRisk factorsAssociated with atherosclerosisCoronary atherosclerosisLipoprotein cholesterolAtherosclerotic cardiovascular disease riskSerum non-HDL-COptimal risk factorsLow-risk adultsActive tobacco useCardiovascular disease riskAssociation of low-density lipoprotein cholesterolAsymptomatic middle-aged adultsNon-high-density lipoprotein cholesterolAtherosclerosis prevalenceCoronary computed tomography angiographyHigh-risk plaque featuresMiddle-aged adultsAtherogenic lipoproteinsHigh LDL-CLow-density lipoprotein cholesterolLevels of atherogenic lipoproteinsMultivariate logistic regression
2023
CORONARY ATHEROSCLEROSIS BASED ON ATHEROGENIC LIPOPROTEINS IN AN ASYMPTOMATIC U.S. POPULATION WITHOUT CONVENTIONAL RISK FACTORS: FROM THE MIAMI HEART STUDY
Faridi K, Lahan S, Cainzos-Achirica M, Cury R, Feldman T, Pan A, Fialkow J, Nasir K. CORONARY ATHEROSCLEROSIS BASED ON ATHEROGENIC LIPOPROTEINS IN AN ASYMPTOMATIC U.S. POPULATION WITHOUT CONVENTIONAL RISK FACTORS: FROM THE MIAMI HEART STUDY. Journal Of The American College Of Cardiology 2023, 81: 1824. DOI: 10.1016/s0735-1097(23)02268-4.Peer-Reviewed Original Research
2021
New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims)
Faridi KF, Bhalla N, Atreja N, Venditto J, Khan ND, Wilson T, Fonseca E, Shen C, Yeh RW, Secemsky EA. New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims). The American Journal Of Cardiology 2021, 151: 70-77. PMID: 34053629, DOI: 10.1016/j.amjcard.2021.04.019.Peer-Reviewed Original ResearchConceptsIncident heart failureChronic kidney diseaseAcute myocardial infarctionAdvanced chronic kidney diseaseConcurrent heart failureRecurrent myocardial infarctionHeart failureMyocardial infarctionRisk scoreNational Cardiovascular Data Registry CathPCIChest Pain-MI RegistryHistory of HFNew-onset heart failureTime of MINew heart failureSimplified risk scoreOnset heart failureIndex myocardial infarctionFuture heart failureAfrican American raceSpecific risk factorsCumulative incidenceIndependent predictorsKidney diseaseRisk factors
2019
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids
Faridi KF, Quispe R, Martin SS, Hendrani AD, Joshi PH, Brinton EA, Cruz DE, Banach M, Toth PP, Kulkarni K, Jones SR. Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids. Journal Of Clinical Lipidology 2019, 13: 634-644. PMID: 31320236, DOI: 10.1016/j.jacl.2019.06.001.Peer-Reviewed Original ResearchConceptsLow-density lipoprotein cholesterolRemnant lipoprotein cholesterolLipoprotein cholesterolLipid parametersVertical auto profile ultracentrifugationRLP-C levelsAtherosclerotic cardiovascular diseaseLipid panelMedian ageHighest quintileRisk factorsCardiovascular diseaseSecond quintileFriedewald equationCholesterolQuintileDlRLPParameters correlatesSubject differencesLipidsCohortDisease
2018
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure
Kundi H, Popma JJ, Valsdottir LR, Shen C, Faridi KF, Pinto DS, Yeh RW. The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. Canadian Journal Of Cardiology 2018, 34: 1648-1654. PMID: 30527154, PMCID: PMC6424362, DOI: 10.1016/j.cjca.2018.10.002.Peer-Reviewed Original ResearchConceptsNontraditional risk factorsLong-term mortalityNoncardiac risk factorsMitral valve repairRisk factorsValve repairMitraClip procedureClaims dataLong-term mortality riskPercutaneous mitral valve repairTranscatheter mitral valve repairPredicting Long-Term MortalityCardiac risk factorsPresentation characteristicsCox regression modelAdministrative claims dataRisk prediction modelMedian followMitraClip implantationModel discriminationMortality riskClaims codesMedicare feePatientsService beneficiariesUtilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval
Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW. Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval. The American Journal Of Cardiology 2018, 121: 1365-1372. PMID: 29627105, DOI: 10.1016/j.amjcard.2018.02.016.Peer-Reviewed Original ResearchConceptsPercutaneous mitral valve repairMitral valve repairValve repairHospital volumeClinical comorbiditiesReduced hospital readmissionsHospital mortality rateDays of dischargeIn-Hospital MortalityNationwide Readmissions DatabaseAdministrative claims databaseHospital readmission ratesRoutine clinical practiceDevice approvalCause mortalityHospital deathMultivariable adjustmentPatient demographicsReadmission ratesHospital readmissionMitraClip deviceClaims databaseHospital characteristicsRisk factorsProcedural volume